| Bioactivity | PBI-1393 (BCH-1393) is an anticancer agent that enhances Th1 type cytokine production and primary T cell activation[1]. |
| CAS | 175072-12-5 |
| Formula | C19H31N9O4 |
| Molar Mass | 449.51 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Mustapha Allam, et al. Enhancement of Th1 type cytokine production and primary T cell activation by PBI-1393. Clin Immunol. 2007 Dec;125(3):318-27. |